companydata.dkcompanydata.dk

AFFITECH A/S: Financial statements 2017

CVR: 14538372

Source: annual report 2017, Danish Business Authority

01/01/2017 – 31/12/2017

AFFITECH A/S (CVR 14538372) has filed annual accounts for 2017. In 2017, the company reported a net result of DKK 24,013,220 compared with DKK -1,992,845 the year before. Equity in the 2017 report amounted to DKK -9,055,237.

Profit/Loss
DKK 24,013,220
Equity
DKK -9,055,237
Total Assets
DKK 7,521,337

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2017--24M-9.1M-
2016---2M-33.1M-
20150-1.5M-31.1M-
2014189K189K-81.6M-32.5M-
201318.7M10.3M-17.8M49M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on AFFITECH A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2017

AFFITECH A/S: The 2016 annual report is outJul 6, 2017

AFFITECH A/S has published its annual report for 2016. The net result was DKK -1,992,845.

Daniil Talyanskiy joins the board of AFFITECH A/SJun 14, 2017

As of June 14, 2017, Daniil Talyanskiy has joined the board of directors of AFFITECH A/S.

Aleksandr Andryushechkin joins the board of AFFITECH A/SJun 14, 2017

As of June 14, 2017, Aleksandr Andryushechkin has joined the board of directors of AFFITECH A/S.

Andrey Petrov leaves the board of AFFITECH A/SJun 14, 2017

As of June 14, 2017, Andrey Petrov has left the board of directors of AFFITECH A/S.

Egor Vasetskiy steps down as vice chairman of AFFITECH A/SJun 14, 2017

As of June 14, 2017, Egor Vasetskiy has stepped down as vice chairman of AFFITECH A/S.

Alexander Duncan steps down as director of AFFITECH A/SJun 10, 2017

As of June 10, 2017, Alexander Duncan has stepped down as director of AFFITECH A/S.

About AFFITECH A/S

AFFITECH A/S was a Danish company of the type Aktieselskab based in København N, founded in 1990. The company has been dissolved on 2 January 2023. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company was previously named PHARMEXA A/S and M&E BIOTECH A/S. The company has 0 employees (2014). In 2021, the company reported a net result of DKK 20,593,000 compared with DKK 124,803,222 the year before. Equity in the 2021 report amounted to DKK 149,159,000.

Source: annual report 2021, Danish Business Authority